gms | German Medical Science

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2013)

22.10. - 25.10.2013, Berlin

Reducing blood loss by topical application of Quixil® in TKA

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Amadou Cissé - Hôpital St.-Loup, Pompaples, Switzerland

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2013). Berlin, 22.-25.10.2013. Düsseldorf: German Medical Science GMS Publishing House; 2013. DocPO19-941

doi: 10.3205/13dkou712, urn:nbn:de:0183-13dkou7127

Veröffentlicht: 23. Oktober 2013

© 2013 Cissé.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: The aim of this retrospective study is to document the positive effect of intraoperative Quixil® application on overall blood loss after TKA.

Methods: All patients needed a TKA for classical osteoarthritis and surgery was performed by the same surgeon in a standard technique using a tourniquet in all cases. In group one, 70 patients benefited from a classical postoperative auto transfusion and in group two 51 patients were treated with Quixil® application only, before wound closing. Both groups were age and sex matched. We compared the intraoperative blood loss, the difference between pre-and postoperative haemoglobin, the blood transfusion rate, the complication rate and the length of the hospitalisation.

Results and conclusion: We could show that the use of Quixil® significantly decreased the difference between pre- and postoperative haemoglobin value.

The blood transfusion rate was decreased as well as the length of the hospitalisation stay but these results were not statistically significant, the number of patients turned out to be too small

The use of Quixil® in TKA leads to reduction of the overall blood loss,decreases the need for allogeneic blood transfusion.

It seems to shorten the length of the hospitalisation and to accelerate the overall functional recovery.

We observed no complication related to Quixil® and continue to use it routinely in TKA.